Simultaneous inhibition of CXCR1/CXCR2, TGF-β, and PD-L1 overcomes immune resistance driven by tumor plasticity.

被引：0
|
作者：
Horn, Lucas A. [1 ]
Riskin, Jeffrey [1 ]
Hempel, Heidi A. [1 ]
Lind, Hanne [1 ]
Fousek, Kristen [1 ]
Hamilton, Duane H. [1 ]
McCampbell, Kristen K. [1 ]
Schlom, Jeffrey [1 ]
Palena, Claudia [1 ]
机构：
[1] NCI, Lab Tumor Immunol & Biol, CCR, NIH, Bethesda, MD 20892 USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2020年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B43
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [1] Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity
    Horn, Lucas A.
    Riskin, Jeffrey
    Hempel, Heidi A.
    Fousek, Kristen
    Lind, Hanne
    Hamilton, Duane H.
    McCampbell, Kristen K.
    Maeda, Dean Y.
    Zebala, John A.
    Su, Zhen
    Schlom, Jeffrey
    Palena, Claudia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [2] CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice
    Mattos, Matheus Silverio
    Ferrero, Maximiliano Ruben
    Kraemer, Lucas
    Oliveira Lopes, Gabriel Augusto
    Reis, Diego Carlos
    Cassali, Geovanni Dantas
    Silva Oliveira, Fabricio Marcus
    Brandolini, Laura
    Allegretti, Marcello
    Garcia, Cristiana Couto
    Martins, Marco Aurelio
    Teixeira, Mauro Martins
    Russo, Remo Castro
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [3] Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer
    Prajapati, Dipakkumar R.
    Molczyk, Caitlin
    Purohit, Abhilasha
    Saxena, Sugandha
    Sturgeon, Reegan
    Dave, Bhavana J.
    Kumar, Sushil
    Batra, Surinder K.
    Singh, Rakesh K.
    CANCER LETTERS, 2023, 563
  • [4] Dual targeting of TGF-ß and PD-L1 inhibits tumor growth in TGF-ß/PD-L1-driven colorectal carcinoma
    Khalili-Tanha, Ghazaleh
    Fiuji, Hamid
    Gharib, Masoumeh
    Moghbeli, Meysam
    Khalili-Tanha, Nima
    Rahmani, Farzad
    Shakour, Neda
    Maftooh, Mina
    Hassanian, Seyed Mahdi
    Asgharzadeh, Fereshteh
    Shahidsales, Soodabeh
    Anvari, Kazem
    Mozafari, M. R.
    Ferns, Gordon A.
    Batra, Jyotsna
    Giovannetti, Elisa
    Khazaei, Majid
    Avan, Amir
    LIFE SCIENCES, 2023, 328
  • [5] Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer
    Grégoire de Streel
    Charlotte Bertrand
    Nicolas Chalon
    Stéphanie Liénart
    Orian Bricard
    Sara Lecomte
    Julien Devreux
    Mélanie Gaignage
    Gitte De Boeck
    Lore Mariën
    Inge Van De Walle
    Bas van der Woning
    Michael Saunders
    Hans de Haard
    Elien Vermeersch
    Wim Maes
    Hans Deckmyn
    Pierre G. Coulie
    Nicolas van Baren
    Sophie Lucas
    Nature Communications, 11
  • [6] Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer
    de Streel, Gregoire
    Bertrand, Charlotte
    Chalon, Nicolas
    Lienart, Stephanie
    Bricard, Orian
    Lecomte, Sara
    Devreux, Julien
    Gaignage, Melanie
    De Boeck, Gitte
    Marien, Lore
    Van de Walle, Inge
    van der Woning, Bas
    Saunders, Michael
    de Haard, Hans
    Vermeersch, Elien
    Maes, Wim
    Deckmyn, Hans
    Coulie, Pierre G.
    van Baren, Nicolas
    Lucas, Sophie
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [7] Combined Inhibition of TGF- Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models
    Sow, Heng Sheng
    Ren, Jiang
    Camps, Marcel
    Ossendorp, Ferry
    ten Dijke, Peter
    CELLS, 2019, 8 (04)
  • [8] Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and neck cancer models
    Horn, Lucas A.
    Lind, Hanne
    Fousek, Kristen
    Qin, Haiyan
    Rajabian, Nika
    Angstadt, Shantel
    Hsiao-Sanchez, Nicole
    Medina-Enriquez, Miriam M.
    Kelly, Marcus D.
    Allen, Clint T.
    Hammoudeh, Sarah M.
    Weigert, Roberto
    Maeda, Dean Y.
    Zebala, John A.
    Palena, Claudia
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [9] Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion
    Lan, Yan
    Moustafa, Mahmoud
    Knoll, Maximilian
    Xu, Chunxiao
    Furkel, Jennifer
    Lazorchak, Adam
    Yeung, Tsz-Lun
    Hasheminasab, Sayed-Mohammad
    Jenkins, Molly
    Meister, Sarah
    Yu, Huakui
    Schlegel, Julian
    Marelli, Bo
    Tang, Zili
    Qin, Guozhong
    Klein, Carmen
    Qi, Jin
    Zhou, Cheng
    Locke, George
    Krunic, Damir
    Derner, Melissa
    Schwager, Christian
    Fontana, Rachel
    Kriegsmann, Katharina
    Jiang, Feng
    Rein, Katrin
    Kriegsmann, Mark
    Debus, Juergen
    Lo, Kin-Ming
    Abdollahi, Amir
    CANCER CELL, 2021, 39 (10) : 1388 - +
  • [10] CXCR1 AND CXCR2 CHEMOKINE RECEPTOR AGONISTS PRODUCED BY TUMORS INDUCE NEUTROPHIL EXTRACELLULAR TRAPS THAT INTERFERE WITH IMMUNE CYTOTOXICITY
    Teijeira, Alvaro
    Garasa, Saray
    Migueliz, Itziar
    Cirella, Assunta
    Melero, Ignacio
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A453 - A453
12345